Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 2014 Jun;82(6):2160–2161. doi: 10.1128/IAI.01830-14

Lipid A Is More than Acyl Chains

Michael A Apicella 1,
Editor: R P Morrison
PMCID: PMC4019152  PMID: 24711566

Abstract

The acyl chain length, number, and distribution have been considered the major factors contributing to this biological activity of lipid A. The charged head groups on the dihexosamine backbone have also been implicated in contributing to this biology. In Neisseria, it has now been shown that loss of the 4′ phosphoethanolamine has an impact on virulence in an animal model and on the organism's susceptibility to cationic antimicrobial peptides. Such studies offer potential insight into targets for novel antimicrobial agents.

TEXT

In this issue of Infection and Immunity, Packiam and coworkers (1) have demonstrated that phosphoethanolamine decoration of gonococcal lipid A both protects the organism from innate immune factors and is involved in the induction of immunostimulatory factors. These investigators have shown that purified lipooligosaccharide (LOS) from a phosphoethanolamine transferase (lptA) mutant and an lptA LOS mutant strain induced significantly lower levels of NF-κB in tissue murine embryonic fibroblasts and in a female mouse model of lower genital tract infection than LOS from the wild type. In addition, the mutant strain was more sensitive to human and murine cathelicidins. Previous studies had shown that the lptA mutant was less fit than the wild-type strain in an experimental model of competitive gonococcal infection in men (2).

The LOSs of N. gonorrhoeae has been shown to play a role in the pathogenesis of human infections (35). The LOS is composed of three major components: the oligosaccharide chain extensions, the core region, and lipid A (68). The oligosaccharide extensions of the LOS contain determinants that resemble human glycosphingolipid antigens, which play a role in molecular mimicry (911). Neisseria gonorrhoeae lipid A has a dihexosamine backbone and a hexa-acyl structure (composed of two lauric, two hydroxymyristic, and two myristic acid residues) similar to that of enterobacterial lipopolysaccharide (LPS). The 4′ position of the dihexosamine backbone is replaced with a phosphoethanolamine. This head group structure has been shown by a number of groups to impart a number of important biological features on the gonococcus. It has been shown to be important in the resistance of the organism to cationic antimicrobial peptides, in killing by normal human serum, and in stimulating an inflammatory response (1217).

The importance of the charged LPS head groups on membrane integrity has been known for many years. Leive showed that treatment with EDTA resulted in a loss of approximately 50% of the LPS from the Escherichia coli outer membrane and a resultant increase in the permeability of the cell (18). This resulted from a loss of the divalent cations involved in linking the LPS structures to each other and to membrane proteins. Using synthetic lipid A structures, Kotani and collaborators showed that diphosphoryl structures (e.g., compound 506) were a significantly more potent mitogen and pyrogen than a structure with a monophosphoryl structure (e.g., compound 504) or a nonphosphorylated structure (e.g., compound 505) (19, 20). In 1985, Peterson and coworkers showed that polycationic antibiotics and polyamines bound to head groups, resulting in disruption of the integrity of the outer membrane of Pseudomonas aeruginosa (21). Removal of the head group phosphorylation has been shown to reduce inflammation in Neisseria commensals (14). Recently, Kong and coworkers have shown that the phosphate groups of the lipid A of Salmonella enterica serovar Typhimurium impact both innate immunity and virulence in mice (22).

The role of acyl chains and head groups on the inflammatory response initiated by lipid A has been elucidated by Seydel and coworkers, who have determined its conformation and supramolecular structure (2326). Using biophysical approaches, Seydel and his group have written extensively about the relationship between the conformation of lipid A and its ability to act as an agonist and antagonist (23). They have shown that lipid A modifications in the acyl chain number, distribution of the chains (symmetrical or asymmetrical), and head group substitution were accompanied by a change in the tilt angle of the backbone with respect to the acyl chains, which impact the conformation of the lipid A structure and, potentially, the ability to engage Toll-like receptor 4 (TRL4). They proposed that only those lipid A molecules that assume a conical shape were biologically highly active and that structures assuming a cylindrical shape were antagonistic (23). The loss of head groups causing changes in membrane integrity and the reduction in the ability of modified lipid A to interact with TLR4 most probably explain the loss of the inflammatory response and the enhanced activity of the cationic antimicrobial peptide on the organism.

Thhe paper by Packiam et al. has implications for the development of novel approaches to therapy for gonococcal infections. The recent evolution of antimicrobial resistance to all of the drugs introduced for the treatment of gonorrhea as well as organisms resistant to multiple antibiotics has made the need for new agents imperative (2729). Studies such as this paper and a previous manuscript by Hobbs and coworkers (2), which combine basic experimentation with in vivo analysis of outcome, are crucial in logical antibiotic design. Such approaches will give us new targets for antimicrobial development and, hopefully, new paradigms for treatment (multidrug therapies) to control the increasing problem of antimicrobial resistance in gonococcal infections.

ACKNOWLEDGMENT

I am supported in part by funding from the NIAID through proposals AI108255, AI024616, AI44642, and AI50661.

Footnotes

Published ahead of print 7 April 2014

The views expressed in this Commentary do not necessarily reflect the views of the journal or of ASM.

REFERENCES

  • 1. Packiam M, Yedery R, Begum AA, Carlson RW, Ganguly J, Sempowski GD, Ventevogel MS, Shafer WM, Jerse AE. 2014. Phosphoethanolamine decoration of Neisseria gonorrhoeae lipid A plays a dual immunostimulatory and protective role during experimental genital tract infection. Infect. Immun. 82:2170–2179. 10.1128/IAI.01504-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Hobbs MM, Anderson JE, Balthazar JT, Kandler JL, Carlson RW, Ganguly J, Begum AA, Duncan JA, Lin JT, Sparling PF, Jerse AE, Shafer WM. 2013. Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and men. mBio 4(6):e00892-13. 10.1128/mBio.00892-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Harvey HA, Porat N, Campbell CA, Jennings M, Gibson BW, Phillips NJ, Apicella MA, Blake MS. 2000. Gonococcal lipooligosaccharide is a ligand for the asialoglycoprotein receptor on human sperm. Mol. Microbiol. 36:1059–1070. 10.1046/j.1365-2958.2000.01938.x [DOI] [PubMed] [Google Scholar]
  • 4. Harvey HA, Jennings MP, Campbell CA, Williams R, Apicella MA. 2001. Receptor-mediated endocytosis of Neisseria gonorrhoeae into primary human urethral epithelial cells: the role of the asialoglycoprotein receptor. Mol. Microbiol. 42:659–672. 10.1046/j.1365-2958.2001.02666.x [DOI] [PubMed] [Google Scholar]
  • 5. Schneider H, Griffiss JM, Boslego JW, Hitchcock PJ, Zahos KM, Apicella MA. 1991. Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J. Exp. Med. 174:1601–1605. 10.1084/jem.174.6.1601 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. John CM, Griffiss J, Apicella MA, Mandrell RE, Gibson BW. 1991. The Structural Basis for Pyocin Resistance in Neisseria gonorrhoeae Lipooligosaccharides. The J. Biol. Chem. 266:19303–19311 [PubMed] [Google Scholar]
  • 7. Post DM, Phillips NJ, Shao JQ, Entz DD, Gibson BW, Apicella MA. 2002. Intracellular survival of Neisseria gonorrhoeae in male urethral epithelial cells: importance of a hexaacyl lipid A. Infect. Immun. 70:909–920. 10.1128/IAI.70.2.909-920.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Post DM, Ketterer MR, Phillips NJ, Gibson BW, Apicella MA. 2003. The msbB mutant of Neisseria meningitidis strain NMB has a defect in lipooligosaccharide assembly and transport to the outer membrane. Infect. Immun. 71:647–655. 10.1128/IAI.71.2.647-655.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Mandrell RE, Lesse AJ, Sugai JV, Shero M, Griffiss JM, Cole JA, Parsons NJ, Smith H, Morse SA, Apicella MA. 1990. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J. Exp. Med. 171:1649–1664. 10.1084/jem.171.5.1649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Mandrell RE, Apicella MA, Lindstedt R, Leffler H. 1994. Possible interaction between animal lectins and bacterial carbohydrates. Methods Enzymol. 236:231–254. 10.1016/0076-6879(94)36019-7 [DOI] [PubMed] [Google Scholar]
  • 11. Mandrell RE, Apicella MA. 1993. Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiol. 187:382–402. 10.1016/S0171-2985(11)80352-9 [DOI] [PubMed] [Google Scholar]
  • 12. Lewis LA, Shafer WM, Dutta Ray T, Ram S, Rice PA. 2013. Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing. Infect. Immun. 81:33–42. 10.1128/IAI.00751-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Lewis LA, Choudhury B, Balthazar JT, Martin LE, Ram S, Rice PA, Stephens DS, Carlson R, Shafer WM. 2009. Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect. Immun. 77:1112–1120. 10.1128/IAI.01280-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. John CM, Liu M, Phillips NJ, Yang Z, Funk CR, Zimmerman LI, Griffiss JM, Stein DC, Jarvis GA. 2012. Lack of lipid A pyrophosphorylation and functional lptA reduces inflammation by Neisseria commensals. Infect. Immun. 80:4014–4026. 10.1128/IAI.00506-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Liu M, John CM, Jarvis GA. 2010. Phosphoryl moieties of lipid A from Neisseria meningitidis and N. gonorrhoeae lipooligosaccharides play an important role in activation of both MyD88- and TRIF-dependent TLR4-MD-2 signaling pathways. J. Immunol. 185:6974–6984. 10.4049/jimmunol.1000953 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. John CM, Liu M, Jarvis GA. 2009. Natural phosphoryl and acyl variants of lipid A from Neisseria meningitidis strain 89I differentially induce tumor necrosis factor-alpha in human monocytes. J. Biol. Chem. 284:21515–21525. 10.1074/jbc.M109.004887 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Takahashi H, Carlson RW, Muszynski A, Choudhury B, Kim KS, Stephens DS, Watanabe H. 2008. Modification of lipooligosaccharide with phosphoethanolamine by LptA in Neisseria meningitidis enhances meningococcal adhesion to human endothelial and epithelial cells. Infect. Immun. 76:5777–5789. 10.1128/IAI.00676-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Leive L. 1965. Release of lipopolysaccharide by EDTA treatment of E. coli. Biochem. Biophys. Res. Commun. 21:290–296. 10.1016/0006-291X(65)90191-9 [DOI] [PubMed] [Google Scholar]
  • 19. Kotani S, Takada H, Tsujimoto M, Ogawa T, Takahashi I, Ikeda T, Otsuka K, Shimauchi H, Kasai N. 1985. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant. Infect. Immun. 49:225–237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Takada H, Kotani S, Tsujimoto M, Ogawa T, Takahashi I, Harada K, Katsukawa C, Tanaka S, Shiba T, Kusumoto S. 1985. Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs. Infect. Immun. 48:219–227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Peterson AA, Hancock RE, McGroarty EJ. 1985. Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa. J. Bacteriol. 164:1256–1261 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Kong Q, Six DA, Liu Q, Gu L, Wang S, Alamuri P, Raetz CR, Curtiss R., III 2012. Phosphate groups of lipid A are essential for Salmonella enterica serovar Typhimurium virulence and affect innate and adaptive immunity. Infect. Immun. 80:3215–3224. 10.1128/IAI.00123-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Seydel U, Oikawa M, Fukase K, Kusumoto S, Brandenburg K. 2000. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur. J. Biochem. 267:3032–3039. 10.1046/j.1432-1033.2000.01326.x [DOI] [PubMed] [Google Scholar]
  • 24. Schromm AB, Brandenburg K, Loppnow H, Moran AP, Koch MH, Rietschel ET, Seydel U. 2000. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur. J. Biochem. 267:2008–2013. 10.1046/j.1432-1327.2000.01204.x [DOI] [PubMed] [Google Scholar]
  • 25. Schromm AB, Brandenburg K, Loppnow H, Zahringer U, Rietschel ET, Carroll SF, Koch MH, Kusumoto S, Seydel U. 1998. The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J. Immunol. 161:5464–5471 [PubMed] [Google Scholar]
  • 26. Brandenburg K, Seydel U. 2010. Conformation and supramolecular structure of lipid A. Adv. Exp. Med. Biol. 667:25–38. 10.1007/978-1-4419-1603-7_3 [DOI] [PubMed] [Google Scholar]
  • 27. Tapsall JW, Ndowa F, Lewis DA, Unemo M. 2009. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev. Anti Infect. Ther. 7:821–834. 10.1586/eri.09.63 [DOI] [PubMed] [Google Scholar]
  • 28. Unemo M, Nicholas RA. 2012. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 7:1401–1422. 10.2217/fmb.12.117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. 2012. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56:1273–1280. 10.1128/AAC.05760-11 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES